Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-09-28
1993-08-10
Friedman, S. J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142235, 514275, 514422, 514593, 514592, A61K 3154
Patent
active
052349225
ABSTRACT:
Methods for the treatment of secretory diarrhea comprised of administering to a patient in need thereof, an effective amount of a CFTR chloride channel blocker or a potassium channel opener are disclosed. The CFTR chloride channel blocker is a sulfonylurea of the group consisting of tolbutamide, glibenclamide, and related analogs. The potassium channel opener is selected from the group consisting of diazoxide, lemakalim, and minoxidil sulfate.
REFERENCES:
patent: 5100647 (1992-03-01), Agus et al.
Sheppard David N.
Welsh Michael J.
Friedman S. J.
Jarvis William
University of Iowa Research Foundation
LandOfFree
Use of sulfonylureas and other potassium channel regulators to t does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of sulfonylureas and other potassium channel regulators to t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of sulfonylureas and other potassium channel regulators to t will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1725273